1. Home
  2. ILMN vs INVH Comparison

ILMN vs INVH Comparison

Compare ILMN & INVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • INVH
  • Stock Information
  • Founded
  • ILMN 1998
  • INVH 2012
  • Country
  • ILMN United States
  • INVH United States
  • Employees
  • ILMN N/A
  • INVH N/A
  • Industry
  • ILMN Medical Specialities
  • INVH Real Estate
  • Sector
  • ILMN Health Care
  • INVH Finance
  • Exchange
  • ILMN Nasdaq
  • INVH Nasdaq
  • Market Cap
  • ILMN 15.3B
  • INVH 18.1B
  • IPO Year
  • ILMN 2000
  • INVH 2017
  • Fundamental
  • Price
  • ILMN $120.19
  • INVH $28.38
  • Analyst Decision
  • ILMN Hold
  • INVH Buy
  • Analyst Count
  • ILMN 15
  • INVH 16
  • Target Price
  • ILMN $114.93
  • INVH $35.47
  • AVG Volume (30 Days)
  • ILMN 1.9M
  • INVH 4.7M
  • Earning Date
  • ILMN 10-30-2025
  • INVH 10-29-2025
  • Dividend Yield
  • ILMN N/A
  • INVH 4.11%
  • EPS Growth
  • ILMN N/A
  • INVH 32.35
  • EPS
  • ILMN 4.46
  • INVH 0.95
  • Revenue
  • ILMN $4,288,000,000.00
  • INVH $2,689,621,000.00
  • Revenue This Year
  • ILMN N/A
  • INVH $5.73
  • Revenue Next Year
  • ILMN $2.22
  • INVH $3.43
  • P/E Ratio
  • ILMN $26.93
  • INVH $29.75
  • Revenue Growth
  • ILMN N/A
  • INVH 5.29
  • 52 Week Low
  • ILMN $68.70
  • INVH $27.38
  • 52 Week High
  • ILMN $153.06
  • INVH $35.80
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 63.59
  • INVH 47.53
  • Support Level
  • ILMN $118.50
  • INVH $27.69
  • Resistance Level
  • ILMN $125.50
  • INVH $29.14
  • Average True Range (ATR)
  • ILMN 5.19
  • INVH 0.59
  • MACD
  • ILMN 1.13
  • INVH 0.07
  • Stochastic Oscillator
  • ILMN 81.50
  • INVH 54.26

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About INVH Invitation Homes Inc.

Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.

Share on Social Networks: